PACAP-(1-38) as neurotransmitter in pig pancreas: Receptor activation revealed by the antagonist PACAP-(6-38)

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 273, Issue 2 36-2, 1997, Pages

  Tornøe, Karen ^a   Hannibal, Jens ^b   Fahrenkrug, Jan ^b   Holst, Jens Juul ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b BISPEBJERG HOSPITAL   (Denmark)

Author keywords

Endocrine secretion; Exocrine secretion; Immunohistochemistry; Isolated perfused pancreas; Pituitary adenylyl cyclase activating polypeptide

Indexed keywords

GLUCAGON; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE[6-38]; INSULIN; NEUROPEPTIDE RECEPTOR; NEUROTRANSMITTER; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL TISSUE; ARTICLE; ELECTROSTIMULATION; NONHUMAN; PANCREAS JUICE; PANCREAS SECRETION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SWINE; VAGUS NERVE STIMULATION;

EID: 0030800506     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.1997.273.2.g436     Document Type: Article

References (13)

1. Adamou, J. E., N. Aiyar, S. Van Horn, and N. A. Elshourbagy. Cloning and functional characterization of the human vasoactive intestinal peptide (VIP)-2 receptor. Biochem. Biophys. Res. Commun. 209: 385-392, 1995.
2. Aino, H., H. Hashimoto, N. Ogawa, A. Nishino, K. Yamamoto, H. Nogi, S. Nagata, and A. Baba. Structure of the gene encoding the mouse pituitary adenylate cyclase-activating polypeptide receptor. Gene 164: 301-304, 1995.
3. Alonso, R. M., A. M. Rodriguez, L. J. Garcia, M. A. Lopez, and J. J. Calvo. Comparison between the effects of VIP and the novel peptide PACAP on the exocrine pancreatic secretion of the rat. Pancreas 9: 123-128, 1994.
4. Arimura, A. Pituitary adenylate cyclase activating polypeptide (PACAP): discovery and current status of research. Regul. Pept. 37: 287-303, 1992.
5. Arimura, A., and S. Shioda. Pituitary adenylate cyclase activating polypeptide (PACAP) and its receptors: neuroendocrine and endocrine interaction. Front. Neuroendocrinol. 16: 53-88, 1995.
6. Fahrenkrug, J. Vasoactive intestinal polypeptide: measurement, distribution and putative neurotransmitter function. Digestion 19: 149-169, 1979.
7. Fahrenkrug, J., T. Buhl, and J. Hannibal. PreproPACAP-derived peptides occur in VIP-producing tumours and co-exist with VIP. Regul. Pept. 58: 89-98, 1995.
8. Fahrenkrug, J., and J. Hannibal. Pituitary adenylate cyclase activating polypeptide innervation of the rat female reproductive tract and the associated paracervical ganglia: effect of capsaicin. Neuroscience 73: 1049-1060, 1996.
9. Fahrenkrug, J., and O. V. Schaffalitzky de Muckadell. Radioimmunoassay of vasoactive intestinal polypeptide (VIP) in plasma. J. Lab. Clin. Med. 89: 1379-1388, 1977.
10. Fridolf, T., F. Sundler, and B. Ahren. Pituitary adenylate cyclase-activating polypeptide (PACAP): occurrence in rodent pancreas and effects on insulin and glucagon secretion in the mouse. Cell Tissue Res. 269: 275-279, 1992.
11. Gourlet, P., A. Vandermeers, M. C. Vandermeers Piret, J. Rathe, P. de Neef, and P. Robberecht. Fragments of pituitary adenylate cyclase activating polypeptide discriminate between type I and II recombinant receptors. Eur. J. Pharmacol. 287: 7-11, 1995.
12. Hannibal, J., J. D. Mikkelsen, H. Clausen, J. J. Holst, B. S. Wulff, and J. Fahrenkrug. Gene expression of pituitary adenylate cyclase activating polypeptide (PACAP) in the rat hypothalamus. Regul. Pept. 55: 133-148, 1995.
13. Hashimoto, H., T. Ishihara, R. Shigemoto, K. Mori, and S. Nagata. Molecular cloning and tissue distribution of a receptor for pituitary adenylate cyclase-activating polypeptide. Neuron 11: 333-342, 1993.